stella
beta
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation — Stella
Home
/
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
/
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
View on ClinicalTrials.gov
Recruiting
Back to Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 trials
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
United States
Emory Midtown University Hospital/Winship Cancer Institute, Atlanta, Georgia
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow